ST. PAUL, Minn. -- St. Jude Medical, Inc., a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) clearance and will immediately launch the AMPLATZER™ ...

Left atrial appendage (LAA) closure using the Amplatzer cardiac plug is associated with lower than expected risks of systemic thromboembolism and major bleeding in patients with nonvalvular A-fib, ...

AGA Medical Inc. (NASDAQ: AGAM) has enrolled the first patient in a clinical trial of a cardiac device aimed at preventing strokes in patients with abnormal heartbeats. CEO John Barr called the first ...

ST. PAUL, Minn. (AP) -- St. Jude Medical Inc. said Monday that the Food and Drug Administration approved the newest version of its Amplatzer vascular plug. The plug is designed to be used in surgical ...

St. Jude Medical ($STJ) got sideswiped with an FDA safety alert over one of the company's heart plugs based on reports that it could potentially wear away tissue and ...

Abbott has received a new, broad approval from the FDA for its tiny heart plug implant to help cut down the risk of stroke among people with atrial fibrillation, the most common cardiac arrhythmia.

MINNEAPOLIS, Aug. 24 AGA Medical Corporation ("AGA")announced today that it has received U.S. Food and Drug Administration (FDA)and European CE Mark approvals for the AMPLATZER Vascular Plug II ...

Abbott Laboratories (NYSE:ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles (air emboli) to be introduced into patients who have procedures with this ...

Abbott is recalling the Amplatzer steerable delivery sheath, used to deliver the Amplatzer Amulet left atrial appendage occluder during cardiac catheterization, because of an increased risk of air ...

Abbott’s Amplatzer Amulet Left Atrial Appendage Occluder was approved nearly two years ago. Here are five things to know about the minimally invasive device: 1. The product closes the left atrial ...